Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Luukkainen, R.
Right arrow Articles by Kajander, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Luukkainen, R.
Right arrow Articles by Kajander, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1978 All rights reserved

Gold Treatment at an Early Stage of Rheumatoid Arthritis

R. Luukkainen, H. Isomäki and A. Kajander


  Abstract

The progression of erosive X-ray changes over a period of 5–6 years was evaluated in 39 patients exposed to a mean dose of 2030 mg aurothiomalate during the maintenance period. The cause for the low dose was the initial high incidence of side-effects.

The progression of erosions was highest in patients with the low dose of gold in the initial stages of the disease.

The best result in preventing development of erosions was achieved in patients with the high dose of gold in the early phase of the disease.

It appears that gold treatment prevents the progression of the erosions. The earlier the inception of treatment, the better the result.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.